Skip to main content
Help us improve emc by letting us know which of the following best describes you
Patient or Carer
Healthcare Professional
Other Professional
Toggle navigation
Home
Medicines
COVID-19 VACCINES
Browse Medicine A-Z
Browse Active Ingredient A-Z
Medicines with Black Triangle
Discontinued Medicines
Report Side Effect
RMM Directory
Companies
Latest Updates
About emc
Help
Sign up
|
Log in
Search emc: Enter medicine name or company
Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
GO
Advanced Search >
Search results for
Rituximab
9 results found
Save this search
Page 1 of 1
Filter Search Results
Sort by
Product Name A to Z
Product Name Z to A
Company Name A to Z
Company Name Z to A
Updated - Newest First
Updated - Oldest First
Medicine Information for...
Healthcare Professionals (SmPC)
Patients (PIL)
Includes material to help reduce the risk associated with using this medicine (RMM)
This medicine is subject to additional monitoring
Includes patient information for visually impaired
Legal Categories
POM - Prescription only Medicine
Active Ingredients
rituximab
Companies
Napp Pharmaceuticals Limited
Pfizer Limited
Roche Products Limited
Sandoz Limited
Back to top
MabThera 100 mg Concentrate for Solution for Infusion
rituximab
Roche Products Limited
SmPC
Patient Leaflet
Risk Materials
MabThera 1400 mg Solution for Subcutaneous Injection
rituximab
Roche Products Limited
SmPC
Patient Leaflet
Risk Materials
MabThera 500 mg concentrate for solution for infusion
rituximab
Roche Products Limited
SmPC
Patient Leaflet
Risk Materials
Rixathon 100 mg concentrate for solution for infusion
rituximab
Sandoz Limited
SmPC
Risk Materials
Rixathon 500 mg concentrate for solution for infusion
rituximab
Sandoz Limited
SmPC
Risk Materials
Ruxience 100 mg concentrate for solution for infusion
rituximab
Pfizer Limited
SmPC
Patient Leaflet
Risk Materials
Ruxience 500 mg concentrate for solution for infusion
rituximab
Pfizer Limited
SmPC
Patient Leaflet
Risk Materials
Truxima 100 mg concentrate for solution for infusion
rituximab
Napp Pharmaceuticals Limited
SmPC
Patient Leaflet
Risk Materials
Truxima 500 mg concentrate for solution for infusion
rituximab
Napp Pharmaceuticals Limited
SmPC
Patient Leaflet
Risk Materials
Page 1 of 1
×
Save this search
Search name
Name this search
Please provide a name for this search
Enter a description
Name this search
;
Skip to main content
